Injection of the sciatic nerve with TMEV: a new model for peripheral nerve demyelination
- PMID: 17028060
- PMCID: PMC1847644
- DOI: 10.1016/j.virol.2006.09.009
Injection of the sciatic nerve with TMEV: a new model for peripheral nerve demyelination
Abstract
Demyelination of the human peripheral nervous system (PNS) can be caused by diverse mechanisms including viral infection. Despite association of several viruses with the development of peripheral demyelination, animal models of the condition have been limited to disease that is either autoimmune or genetic in origin. We describe here a model of PNS demyelination based on direct injection of sciatic nerves of mice with the cardiovirus, Theiler's murine encephalomyelitis virus (TMEV). Sciatic nerves of FVB mice develop inflammatory cell infiltration following TMEV injection. Schwann cells and macrophages are infected with TMEV. Viral replication is observed initially in the sciatic nerves and subsequently the spinal cord. Sciatic nerves are demyelinated by day 5 post-inoculation (p.i.). Injecting sciatic nerves of scid mice resulted in increased levels of virus recovered from the sciatic nerve and spinal cord relative to FVB mice. Demyelination also occurred in scid mice and by 12 days p.i., hindlimbs were paralyzed. This new model of virus-induced peripheral demyelination may be used to dissect processes involved in protection of the PNS from viral insult and to study the early phases of lesion development.
Figures





Similar articles
-
Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination.J Neuroimmunol. 2001 Aug 30;118(2):256-67. doi: 10.1016/s0165-5728(01)00338-1. J Neuroimmunol. 2001. PMID: 11498260
-
Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.Viral Immunol. 2009 Dec;22(6):371-87. doi: 10.1089/vim.2009.0052. Viral Immunol. 2009. PMID: 19951174 Free PMC article.
-
Apoptotic cells, including macrophages, are prominent in Theiler's virus-induced inflammatory, demyelinating lesions.J Virol. 2003 Apr;77(7):4383-8. doi: 10.1128/jvi.77.7.4383-4388.2003. J Virol. 2003. PMID: 12634394 Free PMC article.
-
[Persistentent infection and demyelination induced by Theiler's murine encephalomyelitis virus (TMEV)].Uirusu. 1999 Dec;49(2):175-81. doi: 10.2222/jsv.49.175. Uirusu. 1999. PMID: 10737115 Review. Japanese. No abstract available.
-
Theiler's murine encephalomyelitis virus (TMEV): the role of a small out-of-frame protein in viral persistence and demyelination.Jpn J Infect Dis. 1999 Dec;52(6):228-33. Jpn J Infect Dis. 1999. PMID: 10738359 Review.
Cited by
-
Surgically Induced Demyelination in Rat Sciatic Nerve.Brain Sci. 2023 May 3;13(5):754. doi: 10.3390/brainsci13050754. Brain Sci. 2023. PMID: 37239226 Free PMC article.
-
Comparison of Theiler's Murine Encephalomyelitis Virus Induced Spinal Cord and Peripheral Nerve Lesions Following Intracerebral and Intraspinal Infection.Int J Mol Sci. 2019 Oct 16;20(20):5134. doi: 10.3390/ijms20205134. Int J Mol Sci. 2019. PMID: 31623261 Free PMC article.
-
A subgenomic segment of Theiler's murine encephalomyelitis virus RNA causes demyelination.J Virol. 2008 Jun;82(12):5879-86. doi: 10.1128/JVI.02432-07. Epub 2008 Apr 9. J Virol. 2008. PMID: 18400855 Free PMC article.
-
Host genetic diversity drives variable central nervous system lesion distribution in chronic phase of Theiler's Murine Encephalomyelitis Virus (TMEV) infection.PLoS One. 2021 Aug 20;16(8):e0256370. doi: 10.1371/journal.pone.0256370. eCollection 2021. PLoS One. 2021. PMID: 34415947 Free PMC article.
-
The L-coding region of the DA strain of Theiler's murine encephalomyelitis virus causes dysfunction and death of myelin-synthesizing cells.J Virol. 2011 Sep;85(18):9377-84. doi: 10.1128/JVI.00178-11. Epub 2011 Jul 13. J Virol. 2011. PMID: 21752920 Free PMC article.
References
-
- Bernhardt G, Bibb JA, Bradley J, Wimmer E. Molecular characterization of the cellular receptor for poliovirus. Virol. 1994;199:105–113. - PubMed
-
- Bitan M, Or R, Shapira MY, Mador N, Resnick IB, Saleh N, Weinberger KM, Samuel S, Schechter E, Slavin S, Wolf DG. Early-onset Guillain-Barre syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation. Clin Infect Dis. 2004;39:1076–1078. - PubMed
-
- Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature. 1983;301:527–530. - PubMed
-
- Bour-Jordan H, Thompson HL, Bluestone JA. Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice. J Immunol. 2005;175:5649–5655. - PubMed
-
- Brannagan TH, 3, Zhou Y. HIV-associated Guillain-Barre syndrome. J Neurol Sci. 2003;208:39–42. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical